Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Elyse S. Rafal"'
Autor:
Darryl Toth, Bethanee J. Schlosser, Stephen K. Tyring, Albert I. Wertheimer, Nabil Kerrouche, Elyse S. Rafal, Delphine Bucher, Robert T. Brodell
Publikováno v:
Journal of Dermatological Treatment. 23:26-34
Acne has a significant negative impact on quality of life (QoL): lack of self-confidence, depressive symptoms and suicidal thoughts. The objective was to assess the impact of an initial and continued therapy in severe acne patients through patient-re
Autor:
Ronald P. Savin, Phoebe Rich, Nicholas J. Lowe, Adelaide A Hebert, John J. DiGiovanna, Terry M. Jones, David Rodriguez, Sewon Kang, Jonathan Pak, Elyse S. Rafal, Graeme F. Bryce, Douglas R. Eberhardt, Lawrence F. Eichenfield, David M. Pariser, Stacy Smith, Michael Ondovik, Leena P. Shah, John A. McLane, Alan Menter, Mark Ling, Ko Chin Khoo, Julie Newhouse, Michael Jarratt, Craig B. Langman, Steven Kempers, Dan K. Chalker, Emily Wu, Eduardo Tschen, Sabra Sullivan, Catherine Chin
Publikováno v:
Journal of the American Academy of Dermatology. 51:709-717
Background Adverse changes in bone have been reported for patients undergoing high-dose, long-term (several years) isotretinoin therapy for disorders of cornification. The effect of short-term (4-5 months) therapy at the lower dose recommended for ac
Autor:
Robert J. Pariser, Joseph J. Hong, John S. Strauss, Daniel Stewart, Terry M. Jones, Irving Katz, Jon M. Hanifin, Douglas Eberhardt, Graeme F. Bryce, Anne W. Lucky, Eduardo Tschen, David J. Baginski, Donald P. Lookingbill, David M. Pariser, Lawrence K. Chang, Steven Kempers, Michael Jarratt, Dan K. Chalker, Harry L. Roth, Nicholas J. Lowe, John Arthur Mclane, James J. Leyden, Ronald P. Savin, Elyse S. Rafal, Lynn A. Drake, Eileen E. Leach
Publikováno v:
Journal of the American Academy of Dermatology. 45:196-207
Background: Isotretinoin is a very effective drug for treating severe recalcitrant nodular acne. A new micronized formulation of isotretinoin has been shown to be clinically equivalent to standard isotretinoin with improved bioavailability and minima
Autor:
Graeme F. Bryce, John Arthur Mclane, Lynn A. Drake, Douglas Eberhardt, P. Harry L. Roth, Eduardo Tschen, Daniel Stewart, Eileen E. Leach, Dan K. Chalker, James J. Leyden, Lawrence K. Chang, Michael Jarratt, Anne W. Lucky, Irving Katz, Ronald P. Savin, Jon M. Hanifin, Nicholas J. Lowe, Elyse S. Rafal, David M. Pariser, Donald P. Lookingbill, Steven Kempers, Joseph J. Hong, John S. Strauss, David J. Baginski, Terry M. Jones, Robert J. Pariser
Publikováno v:
Journal of the American Academy of Dermatology. 45:187-195
Background: Isotretinoin is very frequently the drug of choice for the management of severe recalcitrant nodular acne. Recently, a new micronized and more bioavailable formulation of isotretinoin has been developed that permits once-daily administrat
Publikováno v:
Journal of the American Academy of Dermatology. 44:S28-S38
A total of 632 adults with atopic dermatitis applied tacrolimus ointment (0.03% or 0.1%) or vehicle twice daily for up to 12 weeks in two randomized, double-blind studies. This report focuses on the efficacy of tacrolimus ointment in these studies. T
Autor:
Ted A. Hamilton, Elyse S. Rafal, A. J. McMichael, Harvinder S. Talwar, C. E. M. Griffiths, L. J. Finkel, John J. Voorhees
Publikováno v:
British Journal of Dermatology. 135:60-64
Summary Cutaneous atrophy arising from prolonged use of potent topical corticosteroids has long been a concern. Thus, it would be advantageous to find an agent which protects against atrophy produced by corticosteroids but at the same time does not i
Publikováno v:
The Journal of clinical and aesthetic dermatology. 1(2)
Objective: This study further assessed the long-term safety and efficacy of fluorouracil cream 0.5% in patients with multiple actinic keratosis (AK) on the face/anterior scalp and other body sites. Design/setting: This 18-month, prospective, open-lab
Publikováno v:
Cutis. 85(5)
This prospective 18-month, open-label, multicenter study assessed the long-term safety and efficacy of fluorouracil cream 0.5% in 277 participants with multiple actinic keratoses (AKs) on the face/anterior scalp and other body sites. Two treatment/ob
Publikováno v:
Journal of Investigative Dermatology. 97(6):1048-1052
Twenty-five patients with extensive psoriasis were randomly assigned into one of three groups, each receiving 0.5 mg/kg of oral liquid methoxsalen photochemotherapy followed 1 h later by exposure to long-wave ultraviolet light (UVA). The sole differe
Autor:
James E. Rasmussen, Elyse S. Rafal
Publikováno v:
Journal of the American Academy of Dermatology. 25:928-932
Sporotrichosis is extremely rare in infants. This report describes an 84-day-old girl with fixed cutaneous sporotrichosis, presumably transmitted by a cat. A rapid, complete response to a low dose of oral potassium iodide therapy was attained. To our